Chemical Name: 4,6-Dichloro-3-[(1E)-3-oxo-3-(phenylamino)-1-propenyl]-1H-indole-2-carboxylic acid sodium salt
Biological ActivityHighly potent and selective non-competitive antagonist acting at the strychnine-insensitive glycine binding site of the NMDA receptor-channel complex (Kd = 0.8 nM). Displays > 1000-fold selectivity over NMDA, AMPA and kainate binding sites. Orally bioavailable and active in vivo.
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Substituted indole-2-carboxylates as in vivo potent antagonists acting at the strychnine-insensitive glycine binding site.
Di Fabio et al.
Receptor binding characteristics of the novel NMDA receptor glycine site antagonist [3H]GV150526A in rat cerebral cortical membranes.
Mugnaini et al.
Pharmacokinetics, metabolism and excretion of the glycine antagonist GV150526A in rat and dog.
Kajbaf et al.
No product specific FAQs exist for this product, however you mayView all Small Molecule FAQs
Reviews for Gavestinel
There are currently no reviews for this product. Be the first to review Gavestinel and earn rewards!
Have you used Gavestinel?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image